IFNG and neoplasm: Several recent studies have reported that IFN-γ induces PD-L1 expression in tumor cells by activating STAT1 signaling, suggesting a possibility on the effectiveness of immunotherapy targeting IFN-γ-induced PD-L1 expression [17–20].